Gastroenterologist's Guide to Assess for Alcohol Use

Area of Science:

• Hepatology
• Addiction Medicine
• Diagnostic Tools

Background:

• Alcohol-associated liver disease (ALD) is a major cause of hospitalization and liver transplantation.
• Delayed diagnosis of ALD due to asymptomatic heavy alcohol use presents a significant challenge.
• Accurate alcohol consumption assessment is vital, especially with alcohol's impact on steatotic liver disease.

Purpose of the Study:

• To review challenges in assessing alcohol use.
• To highlight the importance of subjective alcohol assessment methods.
• To examine objective tools available for quantifying alcohol consumption.

Main Methods:

• PubMed database search for studies on ALD epidemiology, self-reporting tools, and biomarkers.
• Review of relevant articles and references for inclusion in the analysis.
• Focus on alcohol assessment in general and chronic liver disease patient populations.

Main Results:

• Brief questionnaires are recommended for initial alcohol use screening in all patients.
• Positive screening necessitates detailed alcohol assessments.
• Patients with steatotic or chronic liver disease require thorough evaluation, including objective biomarkers to supplement self-reports.
• Discrepancies between subjective and objective reports offer opportunities for patient engagement and treatment planning.

Conclusions:

• Effective alcohol use assessment integrates both objective biomarkers and subjective self-reporting tools.
• Early identification of harmful alcohol use and timely intervention can prevent severe ALD complications.
• Referral to treatment is key to managing alcohol use and mitigating liver disease progression.